Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Environmental Influences Important in Determining Microbiome Composition

By LabMedica International staff writers
Posted on 13 Mar 2018
The contribution of an individual's genetic heritage is much less important than environmental factors in determining the makeup of his or her personal microbiome.

Many studies have indicated that the microbiome affects nearly every aspect of health; and its microbial composition, which varies from individual to individual, may influence areas ranging from weight gain to moods. More...
Human gut microbiome composition is shaped by multiple factors but the relative contribution of host genetics has not been determined.

In a study published in the February 28, 2018, online edition of the journal Nature, investigators at the Weizmann Institute of Science (Rehovot, Israel) examined genotype and microbiome data from 1,046 healthy individuals with several distinct ancestral origins who shared a relatively common environment. In addition to genetic data and microbiome composition, the investigators collected information for each study participant that included dietary habits, lifestyle, medications, and additional measurements.

Results obtained during the study demonstrated that the gut microbiome was not significantly associated with genetic ancestry, and that host genetics had a minor role in determining microbiome composition. In contrast, there were significant similarities in the compositions of the microbiomes of genetically unrelated individuals who shared a household, and that over 20% of the inter-person microbiome variability was associated with factors related to diet, drugs, and internal and external body measurements.

In addition, the investigators demonstrated that microbiome data significantly improved the prediction accuracy for many human traits, such as glucose and obesity measurements, compared to models that used only host genetic and environmental data.

Senior author Dr. Eran Segal, professor of computer science and applied mathematics at the Weizmann Institute of Science, said, "We cannot change our genes, but we now know that we can affect - and even reshape - the composition of the different kinds of bacteria we host in our bodies. So the findings of our research are quite hopeful; they suggest that our microbiome could be a powerful means for improving our health."

Related Links:
Weizmann Institute of Science


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
All-in-One Molecular System
AIO M160
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.